Algo version: 0.98b
Novo Nordisk A/S is listed at the NYSE Exchange
Novo Nordisk A/S [NVO]
NYSE Sector: Healthcare Industry:Biotechnology

Is Novo Nordisk A/S stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Novo Nordisk A/S pays dividends. Last time was Monday 26th of August 2024 where the investors holding the stock on Friday 16th of August 2024 were paid $0.07584705 per share. Over the last 55 times between 1982 and 2024, Novo Nordisk A/S has paid $6.50220705 with an average of $0.12 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Novo Nordisk A/S 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $25.33, you would have made a profit of $105.81 per share or 417.73%

Yes, the average daily trading liquidity for Novo Nordisk A/S is $3.89 million. You should therefore be able to get in and out of your positions relatively fast.

Novo Nordisk A/S has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 3.47, the company's ability to pay off the debt is good. Novo Nordisk A/S has a very good net profit margin of 36.55% and should have very high tolerances against inflation.

We have calculated the inflation risk for Novo Nordisk A/S to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.